# Carriage Services Inc: financial statements, quarterly

CSV · NYSE · CIK 1016281 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/csv.md) · [Financials](/companies/csv/financials.md) · [Filings](/companies/csv/filings.md) · [Insiders](/companies/csv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [90.5](/filings/0001016281-24-000170.md) | [98.8 d](/filings/0001016281-26-000021.md) | [103](/filings/0001016281-25-000077.md) | [102](/filings/0001016281-25-000103.md) | [101](/filings/0001016281-25-000128.md) | [97.7 d](/filings/0001016281-26-000021.md) | [107](/filings/0001016281-26-000037.md) | [102](/filings/0001016281-26-000055.md) | [103](/filings/0001016281-25-000128.md) | [105 d](/filings/0001016281-26-000021.md) | [106](/filings/0001016281-26-000037.md) | [103](/filings/0001016281-26-000055.md) |
| Cost of revenue | $m | [63.1](/filings/0001016281-24-000170.md) | [64.2 d](/filings/0001016281-26-000021.md) | [66.2](/filings/0001016281-25-000077.md) | [65.3](/filings/0001016281-25-000103.md) | [65.2](/filings/0001016281-25-000128.md) | [64.1 d](/filings/0001016281-26-000021.md) | [69.2](/filings/0001016281-26-000037.md) | [66.2](/filings/0001016281-26-000055.md) | [66.5](/filings/0001016281-25-000128.md) | [68.8 d](/filings/0001016281-26-000021.md) | [67.5](/filings/0001016281-26-000037.md) | [67.9](/filings/0001016281-26-000055.md) |
| Gross profit | $m | [27.4](/filings/0001016281-24-000170.md) | [34.6 d](/filings/0001016281-26-000021.md) | [37.3](/filings/0001016281-25-000077.md) | [37.0](/filings/0001016281-25-000103.md) | [35.5](/filings/0001016281-25-000128.md) | [33.6 d](/filings/0001016281-26-000021.md) | [37.8](/filings/0001016281-26-000037.md) | [35.9](/filings/0001016281-26-000055.md) | [36.2](/filings/0001016281-25-000128.md) | [36.7 d](/filings/0001016281-26-000021.md) | [38.6](/filings/0001016281-26-000037.md) | [35.0](/filings/0001016281-26-000055.md) |
| Operating income | $m | [15.7](/filings/0001016281-24-000170.md) | [23.9 d](/filings/0001016281-26-000021.md) | [19.5](/filings/0001016281-25-000077.md) | [18.4](/filings/0001016281-25-000103.md) | [22.9](/filings/0001016281-25-000128.md) | [21.1 d](/filings/0001016281-26-000021.md) | [31.6](/filings/0001016281-26-000037.md) | [24.0](/filings/0001016281-26-000055.md) | [17.5](/filings/0001016281-25-000128.md) | [24.6 d](/filings/0001016281-26-000021.md) | [25.3](/filings/0001016281-26-000037.md) | [24.0](/filings/0001016281-26-000055.md) |
| Interest expense | $m | [9.3](/filings/0001016281-24-000170.md) | [9.1 d](/filings/0001016281-24-000041.md) | [8.7](/filings/0001016281-24-000091.md) | [8.3](/filings/0001016281-24-000132.md) | [8.0](/filings/0001016281-24-000170.md) | [7.0 d](/filings/0001016281-26-000021.md) | [7.3](/filings/0001016281-26-000037.md) | [7.0](/filings/0001016281-26-000055.md) | [6.9](/filings/0001016281-25-000128.md) | [7.1 d](/filings/0001016281-26-000021.md) | [6.9](/filings/0001016281-26-000037.md) | [6.7](/filings/0001016281-26-000055.md) |
| Income tax | $m | [2.1](/filings/0001016281-24-000170.md) | [4.1 d](/filings/0001016281-26-000021.md) | [3.5](/filings/0001016281-25-000077.md) | [3.5](/filings/0001016281-25-000103.md) | [4.9](/filings/0001016281-25-000128.md) | [5.2 d](/filings/0001016281-26-000021.md) | [8.2](/filings/0001016281-25-000077.md) | [5.3](/filings/0001016281-25-000103.md) | [3.4](/filings/0001016281-25-000128.md) | [1.9 d](/filings/0001016281-26-000021.md) | not reported | not reported |
| Net income | $m | [4.6](/filings/0001016281-24-000170.md) | [11.6 d](/filings/0001016281-26-000021.md) | [7.0](/filings/0001016281-25-000077.md) | [6.3](/filings/0001016281-25-000103.md) | [9.9](/filings/0001016281-25-000128.md) | [9.9 d](/filings/0001016281-26-000021.md) | [20.9](/filings/0001016281-26-000037.md) | [11.7](/filings/0001016281-26-000055.md) | [6.6](/filings/0001016281-25-000128.md) | [12.3 d](/filings/0001016281-26-000021.md) | [13.5](/filings/0001016281-26-000037.md) | [12.3](/filings/0001016281-26-000055.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.45](/filings/0001016281-25-000077.md) | [0.40](/filings/0001016281-25-000103.md) | [0.63](/filings/0001016281-25-000128.md) | not reported | [1.34](/filings/0001016281-26-000037.md) | [0.74](/filings/0001016281-26-000055.md) | [0.41](/filings/0001016281-25-000128.md) | not reported | [0.84](/filings/0001016281-26-000037.md) | [0.77](/filings/0001016281-26-000055.md) |
| Basic EPS | $ per share | not reported | not reported | [0.46](/filings/0001016281-25-000077.md) | [0.41](/filings/0001016281-25-000103.md) | [0.65](/filings/0001016281-25-000128.md) | not reported | [1.35](/filings/0001016281-26-000037.md) | [0.75](/filings/0001016281-26-000055.md) | [0.42](/filings/0001016281-25-000128.md) | not reported | [0.86](/filings/0001016281-26-000037.md) | [0.78](/filings/0001016281-26-000055.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.7](/filings/0001016281-23-000132.md) | [1.5](/filings/0001016281-25-000045.md) | [1.7](/filings/0001016281-24-000091.md) | [1.5](/filings/0001016281-24-000132.md) | [1.3](/filings/0001016281-24-000170.md) | [1.2](/filings/0001016281-26-000021.md) | [4.6](/filings/0001016281-25-000077.md) | [1.4](/filings/0001016281-25-000103.md) | [1.2](/filings/0001016281-25-000128.md) | [1.7](/filings/0001016281-26-000055.md) | [2.9](/filings/0001016281-26-000037.md) | [2.6](/filings/0001016281-26-000055.md) |
| Current assets | $m | [40.3](/filings/0001016281-23-000132.md) | [41.7](/filings/0001016281-25-000045.md) | [40.4](/filings/0001016281-24-000091.md) | [43.1](/filings/0001016281-24-000132.md) | [43.6](/filings/0001016281-24-000170.md) | [44.5](/filings/0001016281-26-000021.md) | [49.9](/filings/0001016281-25-000077.md) | [51.3](/filings/0001016281-25-000103.md) | [50.8](/filings/0001016281-25-000128.md) | [56.1](/filings/0001016281-26-000055.md) | [57.1](/filings/0001016281-26-000037.md) | [67.6](/filings/0001016281-26-000055.md) |
| Total assets | $m | [1,255](/filings/0001016281-23-000132.md) | [1,268](/filings/0001016281-26-000021.md) | [1,261](/filings/0001016281-25-000077.md) | [1,269](/filings/0001016281-24-000132.md) | [1,275](/filings/0001016281-24-000170.md) | [1,280](/filings/0001016281-26-000021.md) | [1,275](/filings/0001016281-25-000077.md) | [1,276](/filings/0001016281-25-000103.md) | [1,343](/filings/0001016281-25-000128.md) | [1,346](/filings/0001016281-26-000055.md) | [1,348](/filings/0001016281-26-000037.md) | [1,366](/filings/0001016281-26-000055.md) |
| Current liabilities | $m | [53.3](/filings/0001016281-23-000132.md) | [51.1](/filings/0001016281-25-000045.md) | [56.1](/filings/0001016281-24-000091.md) | [50.8](/filings/0001016281-24-000132.md) | [60.2](/filings/0001016281-24-000170.md) | [58.0](/filings/0001016281-26-000021.md) | [52.5](/filings/0001016281-25-000077.md) | [48.5](/filings/0001016281-25-000103.md) | [57.5](/filings/0001016281-25-000128.md) | [57.2](/filings/0001016281-26-000055.md) | [49.6](/filings/0001016281-26-000037.md) | [46.5](/filings/0001016281-26-000055.md) |
| Total liabilities | $m | [1,094](/filings/0001016281-23-000132.md) | [1,095](/filings/0001016281-25-000045.md) | [1,081](/filings/0001016281-24-000091.md) | [1,081](/filings/0001016281-24-000132.md) | [1,077](/filings/0001016281-24-000170.md) | [1,071](/filings/0001016281-26-000021.md) | [1,052](/filings/0001016281-25-000077.md) | [1,040](/filings/0001016281-25-000103.md) | [1,101](/filings/0001016281-25-000128.md) | [1,091](/filings/0001016281-26-000055.md) | [1,081](/filings/0001016281-26-000037.md) | [1,087](/filings/0001016281-26-000055.md) |
| Long-term debt | $m | [3.3](/filings/0001016281-23-000132.md) | [5.5](/filings/0001016281-25-000045.md) | [5.4](/filings/0001016281-24-000091.md) | [5.4](/filings/0001016281-24-000132.md) | [5.4](/filings/0001016281-24-000170.md) | [4.9](/filings/0001016281-26-000021.md) | [4.9](/filings/0001016281-25-000077.md) | [4.8](/filings/0001016281-25-000103.md) | [6.1](/filings/0001016281-25-000128.md) | [5.6](/filings/0001016281-26-000055.md) | [5.5](/filings/0001016281-26-000037.md) | [5.4](/filings/0001016281-26-000055.md) |
| Current portion of debt | $m | [0.6](/filings/0001016281-23-000132.md) | [0.5](/filings/0001016281-25-000045.md) | [0.6](/filings/0001016281-24-000091.md) | [0.6](/filings/0001016281-24-000132.md) | [0.6](/filings/0001016281-24-000170.md) | [0.6](/filings/0001016281-26-000021.md) | [0.6](/filings/0001016281-25-000077.md) | [0.6](/filings/0001016281-25-000103.md) | [0.6](/filings/0001016281-25-000128.md) | [0.6](/filings/0001016281-26-000055.md) | [0.8](/filings/0001016281-26-000037.md) | [0.8](/filings/0001016281-26-000055.md) |
| Shareholders' equity | $m | [161](/filings/0001016281-24-000170.md) | [173](/filings/0001016281-26-000021.md) | [180](/filings/0001016281-25-000103.md) | [188](/filings/0001016281-25-000128.md) | [198](/filings/0001016281-25-000128.md) | [209](/filings/0001016281-26-000055.md) | [223](/filings/0001016281-26-000055.md) | [235](/filings/0001016281-26-000055.md) | [242](/filings/0001016281-25-000128.md) | [255](/filings/0001016281-26-000055.md) | [267](/filings/0001016281-26-000055.md) | [279](/filings/0001016281-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.7 d](/filings/0001016281-24-000170.md) | [13.7 d](/filings/0001016281-26-000021.md) | [19.7](/filings/0001016281-25-000077.md) | [2.2 d](/filings/0001016281-25-000103.md) | [20.9 d](/filings/0001016281-25-000128.md) | [9.3 d](/filings/0001016281-26-000021.md) | [13.8](/filings/0001016281-26-000037.md) | [8.1 d](/filings/0001016281-26-000055.md) | [24.7 d](/filings/0001016281-25-000128.md) | [14.1 d](/filings/0001016281-26-000021.md) | [14.9](/filings/0001016281-26-000037.md) | [7.6 d](/filings/0001016281-26-000055.md) |
| Capital expenditure | $m | [4.1 d](/filings/0001016281-24-000170.md) | [5.0 d](/filings/0001016281-26-000021.md) | [3.6](/filings/0001016281-25-000077.md) | [3.5 d](/filings/0001016281-25-000103.md) | [4.6 d](/filings/0001016281-25-000128.md) | [4.4 d](/filings/0001016281-26-000021.md) | [3.2](/filings/0001016281-26-000037.md) | [2.8 d](/filings/0001016281-26-000055.md) | [6.7 d](/filings/0001016281-25-000128.md) | [7.9 d](/filings/0001016281-26-000021.md) | [3.9](/filings/0001016281-26-000037.md) | [5.3 d](/filings/0001016281-26-000055.md) |
| Dividends paid | $m | [1.7 d](/filings/0001016281-24-000170.md) | [1.7 d](/filings/0001016281-26-000021.md) | [1.7](/filings/0001016281-25-000077.md) | [1.7 d](/filings/0001016281-25-000103.md) | [1.7 d](/filings/0001016281-25-000128.md) | [1.7 d](/filings/0001016281-26-000021.md) | [1.7](/filings/0001016281-26-000037.md) | [1.8 d](/filings/0001016281-26-000055.md) | [1.8 d](/filings/0001016281-25-000128.md) | [1.8 d](/filings/0001016281-26-000021.md) | [1.8](/filings/0001016281-26-000037.md) | [1.8 d](/filings/0001016281-26-000055.md) |
| Share repurchases | $m | [0.0 d](/filings/0001016281-23-000132.md) | [0.0 d](/filings/0001016281-25-000045.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.5](/filings/0001016281-23-000132.md) | [15.5](/filings/0001016281-24-000091.md) | [15.5](/filings/0001016281-24-000132.md) | [15.5](/filings/0001016281-24-000170.md) | [15.3](/filings/0001016281-25-000077.md) | [15.4](/filings/0001016281-25-000103.md) | [15.5](/filings/0001016281-25-000128.md) | [15.4](/filings/0001016281-26-000037.md) | [15.7](/filings/0001016281-26-000055.md) | [15.7](/filings/0001016281-25-000128.md) | [15.8](/filings/0001016281-26-000037.md) | [15.8](/filings/0001016281-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,882,296 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001016281-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.